REFERENCES
- Danzi S., Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol 2004; 29: 139–50
- Dorr M., Voltzke H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol 2005; 30: 199–216
- Kahaly G.J., Dillmann W.H. Thyroid hormone action in the heart. End Rev 2005; 26: 704–728
- Dorr M., Wolff B., Robinson D.M., John U., Ludemann J., Meng W., Felix S.B., Volzke H. The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab 2005; 90: 673–7
- Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N Eng J Med 2001; 344: 501–9
- Polikar R., Burger A.G., Scherrer U., Nicod P. The thyroid and the heart. Circulation 1993; 87: 1435–1441
- Tang Y.D., Kuzman J.A., Said S., Anderson B.E., Wang X., Gerdes M. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 2005; 112: 3122–3130
- Latour-Perez J., Coves-Orts F.J., Abad-Terrado C., Abraira V., Zamora J. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail 2006; 8: 390–9
- Nielsen L.S., Svanegaard J., Klitgaard N.A., Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnea. Eur J Heart Fail 2004; 6: 63–70
- Hall J. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6: 257–260
- Downie P.F., Talwar S., Squire I.B., Davies J.E., Barnett D.B., Ng L.L. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro : implications for assessment of left ventricular dysfunction. Clin Sci (Lond) 1999; 97: 255–8
- Karl J., Borgya A., Gallusser A., Huber E., Krueger K., Rollinger W., Schenk J. Development of a novel, N-terminal –proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab İnvest Suppl 1999; 230: 177–181
- Liang F., Webb P., Marimuthu A., Zhang S., Gardner D.G. Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 2003; 278: 15073–83
- Bernstein R., Midtbo K., Urdal P., Morkrid L., Smith G., Muller C., Bjoro T., Haug H. Serum N-terminal pro-atrial factor 1–98 before and during thyroxine replacement theraphy in severe hypothyroidism. Thyroid 1997; 7: 415–9
- Diekman M.J., Harms M.P., Endert E., Wieling W., Wiersinga W.M. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroidic patients. Eur J Endocrinol 2001; 144: 339–46
- Schultz M., Faber J., Kistorp C., Jarlov A., Pedersen F., Wiinberg N., Hildebrandt P. N-terminal-pro-B-type natriuretic peptid (NT-proBNP) in different thyroid states. Clin Endocrinol (Oxf) 2004; 60: 54–59
- Christ-Crain M., Morgenthaler N.G., Meier C., Müller C., Nussbaumer C., Bergmann A., Staub J.J., Müller B. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Med Wkly 2005; 135(37–38)549–54
- Wei T., Zeng C., Tian Y., Chen Q., Wang L. B-type natriuretic peptide in patients with clinical hyperthyroidism. J Endocrinol Invest 2005; 28: 8–11
- Manuchehri A.M., Jayagopal V., Kilpatrick E.S., Atkin S.L. The effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide concentrations. Ann Clin Biochem 2006; 43: 184–8
- Kohno M., Horio T., Yasunari K., Yokokawa K., Ikeda M., Kurihara N., Nishizawa Y., Morii H., Takede T. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 1993; 42: 1059–64
- Levey G.S., Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 1990; 88: 642–6
- Hoit B.D., Khoury S.F., Shao Y., Gabel M., Linggett S.B., Walsh R.A. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation 1997; 96: 592–8
- Ojamaa K., Klein I., Sabet A., Steinberg S.F. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Metabolism 2000; 49: 275–9
- Shimoike H., Iwai N., Kinoshita M. Different regulation of natriuretic peptide genes in infracted rat hearts. Clin Exp Pharmacol Physiol 1997; 24: 23–30
- Mair J., Friedl W., Thomas S., Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 1999; 59: 132–142